Large-scale testing (Phase 3)Study completedNCT00048308
What this trial is testing
Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass
Who this might be right for
Cardio-pulmonary BypassCoronary Artery Bypass Graft
Alexion Pharmaceuticals, Inc. 3,000